Form 4 for CL Colgate-Palmolive
Accepted 2026-05-13 16:46:51 ET · period of report 2026-05-11 · accession 0001225208-26-005240 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-13 16:46 | 2026-05-11 | CL | Newman Brian | Dir | A - Grant | $0.00 | +2,075 | 7,621 | +37% | $0 |
| D | 2026-05-13 16:46 | 2026-05-11 | CL | Newman Brian | Dir | A - Grant | $0.00 | +2,424 | 2,424 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-11 | A | A | 2,075 | $0.00 | 7,621 | D | — | — | (F1) Annual director stock grant under the issuer's incentive compensation plan. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-05-11 | A | A | 2,424 | $0.00 | 2,424 | D | $86.74 · — to 2034-05-11 | 2,424 Common Stock | (F2) Annual director stock option grant under the issuer's incentive compensation plan. (F3) Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date. |